Incidence and management of myelosuppression in patients with chronic-and accelerated-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate
Luke Akard, Hagop M. Kantarjian, Franck E. Nicolini, Meir Wetzler, Jeffrey H. Lipton, Michele Baccarani, H. Jean Khoury, Sandra Kurtin, Elizabeth Li, Mihaela Munteanu, Jorge Cortes
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Incidence and management of myelosuppression in patients with chronic-and accelerated-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate'. Together they form a unique fingerprint.